Latest Alzheimer's disease Stories

Researchers have identified a possible treatment window of several years for plaques in the brain that are thought to cause memory loss in diseases such as Alzheimer's. The Mayo Clinic study is published in the Feb. 27 online issue of Neurology, the medical journal of the American Academy of Neurology. "Our study suggests that plaques in the brain that are linked to a decline in memory and thinking abilities, called beta amyloid, take about 15 years to build up and then plateau," says lead...

Collaborative CNS Screening Initiative (CCSI) Aims to Share Knowledge and Speed Drug Discovery NEW YORK, Feb. 28, 2013 /PRNewswire-USNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF), Beyond Batten Disease Foundation (BBDF) and the National Multiple Sclerosis Society today announced a funding collaboration to support the creation of the Collaborative CNS Screening Initiative (CCSI), a central repository of chemical compounds that have shown significant Central Nervous...

EDINA, Minn., Feb. 22, 2013 /PRNewswire/ -- Treatment of Alzheimer's disease is a significant challenge for the medical profession, one that will continue to increase as baby boomers age. Before Alzheimer's can be treated, it must be accurately diagnosed--a challenge in itself. Amyvid, a radioactive dye manufactured by Eli Lilly, was approved by the FDA in April 2012. Amyvid enables clinicians to diagnose with better accuracy, leading to earlier treatment and informed counseling...

A study combining genetic data with brain imaging, designed to identify genes associated with the amyloid plaque deposits found in Alzheimer’s disease patients, has not only identified the APOE gene -- long associated with development of Alzheimer’s -- but has uncovered an association with a second gene, called BCHE. A national research team, led by scientists at the Indiana University School of Medicine, reported the results of the study in an article in Molecular Psychiatry posted...

New findings by Columbia researchers suggest that along with amyloid deposits, white matter hyperintensities (WMHs) may be a second necessary factor for the development of Alzheimer's disease. Most current approaches to Alzheimer's disease focus on the accumulation of amyloid plaque in the brain. The researchers at the Taub Institute for Research on Alzheimer's Disease and the Aging Brain, led by Adam M. Brickman, PhD, assistant professor of neuropsychology, examined the additional...

[ Watch the Video: Scientists Read a Mouse’s Mind ] April Flowers for redOrbit.com - Your Universe Online Researchers at Stanford University have revealed a new technique for observing hundreds of neurons firing in real time in the brain of a live mouse. They have linked this activity to long-term information storage. The unprecedented work, published in a recent issue of Nature Neuroscience, could provide a useful tool for designing new therapies for neurodegenerative diseases such...

MELBOURNE, Fla., Feb. 19, 2013 /PRNewswire-USNewswire/ -- Florida Institute of Technology researchers have won a prestigious grant enabling their biology experiment to travel on a flight to the International Space Station (ISS). Their proposal, "Self-Assembly in Biology and the Origin of Life (SABOL): A Study into Alzheimer's," was just one of eight proposals chosen by Space Florida and NanoRacks, LLC, in the ISS Research Competition. (Logo:...

Multinational Retailer Gives Additional Support to Alzheimer's care, support and research CHICAGO, Feb. 19, 2013 /PRNewswire-USNewswire/ -- Today, the Alzheimer's Association announced a multi-year pledge of $1 million from The TJX Companies, Inc., in recognition of the massive impact of Alzheimer's disease worldwide. This is the second $1 million gift from TJX on behalf of its 168,000 Associates and retail division including T.J. Maxx, Marshalls, HomeGoods and Sierra Trading Post in...

Connie K. Ho for redOrbit.com – Your Universe Online A study from the University of Southern California (USC) recently found that a normal, low-protein diet could slow signs of Alzheimer’s and boost memory in mice. The Alzheimer’s Association defines the disease as a form of dementia related to difficulties with behavior, memory and thinking. In the study, mice with advanced stages of Alzheimer’s disease were put on a new diet. They were given specific amino acids every other...

In a one-year period nearly 700 psychotropic medications have been either discontinued or decreased among people served by the Ecumen Awakenings initiativee in 15 Minnesota nursing homes Minneapolis/St. Paul, Minnesota (PRWEB) February 14, 2013 Ecumen has received Aging Services of Minnesota's Leading Change Innovation Award. The award recognizes Ecumen Awakenings, a initiative to reduce the use of unnecessary antipsychotic and other medications for residents with dementia. About a...